Jon Olav Ødegård • 1973 • Oslo • 14 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
J JOO INVESTMENTS AS	Managing Director/CEO	-	961,493	100 % directly
B BRILLIANT INVEST AS	Managing Director/CEO	-	-38,521,739	7.82 % indirectly
H HBC BERKÅK AS	Managing Director/CEO	796,424	10,546,328	0.74 % indirectly
H HOFSETH BIOCARE ASA	Managing Director/CEO	267,026,000	120,422,000	0.74 % indirectly
H HBC THERAPEUTICS AS	Managing Director/CEO	-	-341,489	0.74 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
J JOO INVESTMENTS AS	Chairman	-	961,493	100 % directly
G GREEN ALKANE TECHNOLOGIES AS	Chairman	-	13,702	30 % indirectly
B BRILLIANT INVEST AS	Chairman	-	-38,521,739	7.82 % indirectly
H HBC BERKÅK AS	Chairman	796,424	10,546,328	0.74 % indirectly
H HBC THERAPEUTICS AS	Chairman	-	-341,489	0.74 % indirectly
H HOFSETH BIOCARE RØRVIK AS	Chairman	-	-1,418,446	-
K KILDA BIOLINK AS	Board Member	-	-5,268,031	-
B BOMI FRAMROZE HOLDING AS	Contact Person	-	-975,852	-

Last update: Dec 31, 2024

Shares owned by Jon Olav Ødegård

Name	Share class	Total operating income	Total equity	Share
J JOO INVESTMENTS AS	Ordinære aksjer	0	961,493	100 % directly
G GREEN ALKANE TECHNOLOGIES AS		0	13,702	30 % indirectly
B BRILLIANT INVEST AS		0	-38,521,739	7.82 % indirectly
H HBC BERKÅK AS		796,424	10,546,328	0.74 % indirectly
H HOFSETH BIOCARE ASA		267,026,000	120,422,000	0.74 % indirectly
H HBC THERAPEUTICS AS		0	-341,489	0.74 % indirectly
A AQUA BIO TECHNOLOGY ASA	NO0013192336	516,293	62,722,660	0.03 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025